Diabetes Core Update – The Road Less Traveled – Less Frequently Used Medications 2019

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. This month, in this special episode titled, “The Road Less Traveled,” sponsored by SalixPharmaceuticals, we will go over the less commonly used glucose lowering agents: Bromocriptine Alpha-glucosidase Inhibitors (Acarbose, Miglitol) Colesevelam Pramlintide For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Abington Jefferson Health

Source: Diabetes Core Update - October 3, 2019 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts